{"nct_id":"NCT02038933","title":"Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2014-03-05","start_date_type":"ACTUAL","primary_completion_date":"2016-04-08","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}